UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001041
Receipt number R000001248
Scientific Title LOWER NORMAL PRESSURE GLAUCOMA STUDY
Date of disclosure of the study information 2008/02/23
Last modified on 2017/02/27 08:30:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

LOWER NORMAL PRESSURE GLAUCOMA STUDY

Acronym

LNPGS

Scientific Title

LOWER NORMAL PRESSURE GLAUCOMA STUDY

Scientific Title:Acronym

LNPGS

Region

Japan


Condition

Condition

Glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clear up many clinical features in the Normal Pressure Glaucoma (NPG) patients (intraocular pressure is less than 15 mmHg) during the time course. To examine the eye-specific and systemic risk factors regarding about the visual field progression. The prospective study (about 165 patients and three observation years) in domestic multi facilities.

Basic objectives2

Others

Basic objectives -Others

Observasional study

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Progression of visual field defect and/or optic disc damage

Key secondary outcomes

Campimetry results with Humphrey automated perimeter,disc hemorrhage and parameter of HRT II and GDx VCC


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Primary open-angle glaucoma patients to fullfill the following criterias.
The intraocular pressure (IOP) lowering drugs are not used or after four weeks or more have passed since the IOP drugs were discontinued, the IOP is 15 mmHg or less excluding one measurement at five times or more measured on different days within six months. The tonometry mesurements should be always less than 21 mmHg. The level of visual field defect: MD of both eyes is more excellent than that of -15 dB.

Key exclusion criteria

An equivalent sphered value is -9.0D less than or +9.0D or more.
Best corrected visual acuity is less than 0.8.
Anamnestic history of any eye surgerys including laser therapy.
Eyes with cataract that influences the visual field.
The patinets who have taken orally hypotensive agents or agents about protection of tissue damege.
The patinets who have troubles such as hepertension (over 160/90) and diabetes mellitus.

Target sample size

165


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Araie Makoto

Organization

Director, Kanto Central Hospital

Division name

Department of Ophthalmology

Zip code


Address

6-25-1, Kamiyouga, Setagaya-ku, 158-8531, Tokyo, Japan

TEL

03-3429-1171

Email

araie-tky@umin.net


Public contact

Name of contact person

1st name
Middle name
Last name Sakata Rei

Organization

The University of Tokyo Hospital

Division name

Department of Ophthalmology

Zip code


Address

7-3-1 Hongo, Bunkyoku, Tokyo, 113-8655 Japan

TEL

03-3815-5411

Homepage URL


Email

reisakata-tky@umin.ac.jp


Sponsor or person

Institute

Japan Glaucoma Society

Institute

Department

Personal name



Funding Source

Organization

Japan Glaucoma Society

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 10 Month 13 Day

Date of IRB


Anticipated trial start date

2007 Year 11 Month 01 Day

Last follow-up date

2015 Year 12 Month 01 Day

Date of closure to data entry

2017 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded

2018 Year 12 Month 01 Day


Other

Other related information

prospective study of background factors for normal tension glaucoma patinets.


Management information

Registered date

2008 Year 02 Month 19 Day

Last modified on

2017 Year 02 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001248


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name